$24 will be next as the $18 target is known to be a low ball park figure.
Griffin Securities Sets Celsion Price Target at $18.00 (CLSN)
The question is, is that to low? Most think it's just that
WRT Griffin at $18. That is is discounted for trial and FDA risk. Once those are taken off, then $18 may be low... but then we will get discounted for performance risk. :-P
way too low, price target for me is $40 early next year after results are given. Thermadox will be the standard of care for cancer treatments. Not just HCC but many cancers. Kill cancer!!!